Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
STEMCELL Technologies FK-866, Size: 10 mg
Supplier: STEMCELL Technologies 1000264
FK-866 is a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme that regulates NAD+ biosynthesis from the natural precursor nicotinamide (Cameron et al.; Hasmann & Schemainda). In hepatocarcinoma cells, FK-866 activates AMP-activated protein kinase (AMPK) and downregulates mammalian target of rapamycin (mTOR) signaling (Schuster et al.). METABOLISM· FK-866 can be used to deplete NAD+, a central metabolism cofactor (Cameron et al.; Hasmann & Schemainda; Jadeja et al.).CANCER RESEARCH· Depletes NAD+ and induces delayed cell death by apoptosis in HepG2 human liver carcinoma cells (IC₅₀ = ~1 nM; Hasmann & Schemainda).· Triggers dose-dependent cytotoxicity in multiple myeloma cells (Cea et al.).· Induces autophagic death in neuroblastoma SH-SY5Y cells (IC₅₀ = 0.93 nM; Billington et al.).
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction